How it works
It mimics GLP-1, a gut hormone released after meals. It slows stomach emptying, lowers appetite and helps the pancreas release insulin when blood sugar is high.
Half-life: about 1 week for the injection, so steady levels take 4 to 5 weeks.
Brands
| Brand | Approved for | How taken | Dose range |
|---|---|---|---|
| Wegovy | Weight | once weekly injection | 0.25 mg to 2.4 mg |
| Ozempic | Type 2 diabetes | once weekly injection | 0.25 mg to 2 mg |
| Wegovy pill | Weight | once daily tablet | 1.5 mg to 25 mg |
| Rybelsus | Type 2 diabetes | once daily tablet | 3 mg to 14 mg |
More on semaglutide
Brand pages
Wegovy
Weekly semaglutide injection for weight management and heart-risk reduction
Open Novo NordiskOzempic
Weekly semaglutide injection for type 2 diabetes, heart and kidney protection
Open Novo NordiskWegovy pill
Daily semaglutide tablet for weight management, the first GLP-1 pill for obesity
Open Novo NordiskRybelsus
Daily semaglutide tablet for type 2 diabetes
OpenExplainer · 0:23
Read the transcript
- After you eat, your gut releases a hormone called GLP-1. GLP-1 medicines copy it, but last much longer in the body.
- It slows how fast your stomach empties, so you feel full sooner and stay full for longer.
- It also acts on appetite centers in the brain, which quiets hunger and constant thoughts about food.
- When blood sugar is high, it helps the pancreas release insulin. Tirzepatide also acts on a second gut hormone, GIP.
Sources
Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error